| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Income taxes payable | 58 | - |
| Deferred tax liabilities | 10 | -14 |
| Net cash used in operating activities | -31,641 | -22,027 |
| Repayments of long-term debt (note 8) | 290 | 290 |
| Net cash provided by (used in) financing activities | -290 | -290 |
| Net increase (decrease) in cash | -31,931 | -22,317 |
| Effect of exchange rate changes on cash | 1,845 | - |
| Cash and cash equivalents at beginning of period | 54,912 | - |
| Cash and cash equivalents at end of period | 24,826 | - |
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)